Eric Devroe

1.1k total citations
12 papers, 914 citations indexed

About

Eric Devroe is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Eric Devroe has authored 12 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Eric Devroe's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (5 papers) and Virus-based gene therapy research (4 papers). Eric Devroe is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (5 papers) and Virus-based gene therapy research (4 papers). Eric Devroe collaborates with scholars based in United States and Germany. Eric Devroe's co-authors include Pamela A. Silver, Alan Engelman, Peter Cherepanov, Ana Limón, Richard Lu, Hediye Erdjument‐Bromage, Paul Tempst, Nick Vandegraaff, Fanny Turlure and Peter Reichardt and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Journal of Virology.

In The Last Decade

Eric Devroe

12 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Devroe United States 10 693 484 385 204 94 12 914
Marc Lavigne France 21 894 1.3× 267 0.6× 243 0.6× 226 1.1× 91 1.0× 29 1.1k
Stuart Le Grice United States 9 755 1.1× 216 0.4× 201 0.5× 106 0.5× 55 0.6× 11 941
William C. Drosopoulos United States 16 715 1.0× 404 0.8× 402 1.0× 81 0.4× 79 0.8× 20 1.1k
Oliver I. Fregoso United States 13 571 0.8× 498 1.0× 276 0.7× 142 0.7× 217 2.3× 19 977
Elizabeth S. Withers-Ward United States 6 349 0.5× 203 0.4× 118 0.3× 109 0.5× 60 0.6× 7 490
Viola Ellison United States 10 1.1k 1.6× 797 1.6× 781 2.0× 121 0.6× 136 1.4× 16 1.5k
Sofie Vets Belgium 12 576 0.8× 447 0.9× 345 0.9× 236 1.2× 111 1.2× 20 830
Laura Bolling United States 7 211 0.3× 204 0.4× 197 0.5× 112 0.5× 55 0.6× 7 646
Gregory A. Sowd United States 15 594 0.9× 494 1.0× 332 0.9× 75 0.4× 157 1.7× 21 957
Sarah Gallois‐Montbrun France 15 518 0.7× 355 0.7× 235 0.6× 52 0.3× 233 2.5× 22 858

Countries citing papers authored by Eric Devroe

Since Specialization
Citations

This map shows the geographic impact of Eric Devroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Devroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Devroe more than expected).

Fields of papers citing papers by Eric Devroe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Devroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Devroe. The network helps show where Eric Devroe may publish in the future.

Co-authorship network of co-authors of Eric Devroe

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Devroe. A scholar is included among the top collaborators of Eric Devroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Devroe. Eric Devroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Devroe, Eric, Benjamin E. Turk, Peter Reichardt, et al.. (2018). Filamin A Phosphorylation at Serine 2152 by the Serine/Threonine Kinase Ndr2 Controls TCR-Induced LFA-1 Activation in T Cells. Frontiers in Immunology. 9. 2852–2852. 24 indexed citations
3.
Devroe, Eric & Pamela A. Silver. (2004). Therapeutic potential of retroviral RNAi vectors. Expert Opinion on Biological Therapy. 4(3). 319–327. 53 indexed citations
4.
Devroe, Eric, Pamela A. Silver, & Alan Engelman. (2004). HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. Virology. 331(1). 181–189. 38 indexed citations
5.
Cherepanov, Peter, Eric Devroe, Pamela A. Silver, & Alan Engelman. (2004). Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase. Journal of Biological Chemistry. 279(47). 48883–48892. 231 indexed citations
6.
Devroe, Eric, Hediye Erdjument‐Bromage, Paul Tempst, & Pamela A. Silver. (2004). Human Mob Proteins Regulate the NDR1 and NDR2 Serine-Threonine Kinases. Journal of Biological Chemistry. 279(23). 24444–24451. 85 indexed citations
7.
Lu, Richard, Ana Limón, Eric Devroe, et al.. (2004). Class II Integrase Mutants with Changes in Putative Nuclear Localization Signals Are Primarily Blocked at a Postnuclear Entry Step of Human Immunodeficiency Virus Type 1 Replication. Journal of Virology. 78(23). 12735–12746. 104 indexed citations
8.
Devroe, Eric & Pamela A. Silver. (2004). Therapeutic potential of retroviral RNAi vectors. Expert Opinion on Biological Therapy. 4(3). 319–327. 1 indexed citations
9.
Devroe, Eric, Alan Engelman, & Pamela A. Silver. (2003). Intracellular transport of human immunodeficiency virus type 1 integrase. Journal of Cell Science. 116(21). 4401–4408. 55 indexed citations
10.
Devroe, Eric & Pamela A. Silver. (2002). Retrovirus-delivered siRNA. BMC Biotechnology. 2(1). 15–15. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026